Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bonk Guy: ANSEM is expected to boost sentiment in the Meme coin market

Bonk Guy: ANSEM is expected to boost sentiment in the Meme coin market

Odaily星球日报Odaily星球日报2026/06/30 05:18
Show original

Odaily reported that crypto KOL Bonk Guy (Unipcs) posted on the X platform saying that although ANSEM has recently attracted significant market attention and achieved a notable price surge, he believes the real biggest beneficiary will be USELESS.

Bonk Guy stated that USELESS has demonstrated strong resilience recently during fluctuations in Bitcoin, Solana, and the overall market, and believes that almost all objective indicators show it has the potential to become the next multi-billion dollar market cap meme coin. These indicators include the position-to-market cap ratio and trading volume-to-market cap ratio, both of which are among the top compared to other meme coins, while its price action remains robust.

Bonk Guy believes that ANSEM’s strength could boost overall market confidence in the meme coin sector and drive renewed focus on this track, with USELESS potentially becoming the biggest beneficiary of this trend.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Citadel warns: Tech stock sell-off is just the first warning sign, AI trading offers "almost no room for error"

The sell-off in tech stocks reflects rising doubts about AI profitability, with Citadel stating that there is very little margin for error in AI trading. Grayscale noted that demand is parabolic, and capital expenditure presents a two-sided risk.

智通财经•2026/10/27 03:08

Daiwa raises Tesla's target price to $390

格隆汇•2026/10/27 02:51
Daiwa raises Tesla's target price to $390

U.S. judge rejects injunction, Novo Nordisk (NVO.US) loses first round in blocking Eli Lilly (LLY.US) weight-loss drug advertisements

On Monday, a U.S. judge dismissed Novo Nordisk's request to prohibit Eli Lilly from continuing to run advertisements for weight-loss drugs. The Danish pharmaceutical company argued that the ads were false and misleading, in a market with annual sales worth tens of billions of dollars.

智通财经•2026/10/27 02:32